Potential cost savings to be made by slowing cognitive decline in mild Alzheimer’s disease dementia using a model derived from the UK GERAS observational study

Lignende værker

• Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer’s disease: 18-month UK results from the GERAS observational study
  af: Alan Lenox-Smith, et al.
  Udgivet: (2016-11-01)
• Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer’s disease: 18-month UK results from the GERAS observational study
  af: Lenox-Smith, Alan, et al.
  Udgivet: (2016)
• Disease Progression in Mild Dementia due to Alzheimer Disease in an 18-Month Observational Study (GERAS): The Impact on Costs and Caregiver Outcomes
  af: Jones, Roy W., et al.
  Udgivet: (2017)
• Excess Costs Associated with Possible Misdiagnosis of Alzheimer’s Disease Among Patients with Vascular Dementia in a UK CPRD Population
  af: Happich, Michael, et al.
  Udgivet: (2016)
• Representativeness of European clinical trial populations in mild Alzheimer’s disease dementia: a comparison of 18-month outcomes with real-world data from the GERAS observational study
  af: Reed, Catherine, et al.
  Udgivet: (2018)